Tachykinin receptor antagonists and cough

被引:18
作者
Advenier, C [1 ]
EmondsAlt, X [1 ]
机构
[1] SANOFI RECH,F-34184 MONTPELLIER,FRANCE
来源
PULMONARY PHARMACOLOGY & THERAPEUTICS | 1996年 / 9卷 / 5-6期
关键词
cough; tachykinin; tachykinin receptor antagonists;
D O I
10.1006/pulp.1996.0043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several potent and selective antagonists for tachykinin receptors are now available and appear as powerful tools to investigate the physiological and pathological roles of tachykinins and to identify the type of receptor involved in their effect. Indeed, a lot of studies have shown that tachykinin NK2 receptor antagonists (SR 48968, MEN 10627) are able to inhibit cough induced by citric acid, capsaicin or allergen challenge in the unanesthetized guinea-pig or mechanical stimulation of the trachea in the cat. The effects of tachykinin NK1 receptor antagonists are still debated, whereas an inhibitory effect of SR 142801, a tachykinin NK3 receptor antagonist, has been reported against citric acid-induced cough in the guinea-pig. Experiments with tachykinin receptor antagonists which do not cross the blood brain barrier suggest that the site of action of tachykinin receptor antagonists is most probably peripheral, but a central action, at least in an area not protected by the blood brain barrier, cannot be excluded. Finally, tachykinin NK2 receptor stimulation seems to be involved in sensitisation of cough reflex. (C) 1996 Academic Press Limited.
引用
收藏
页码:329 / 333
页数:5
相关论文
共 44 条
[1]   ANTITUSSIVE EFFECT OF SR 48968, A NONPEPTIDE TACHYKININ NK(2) RECEPTOR ANTAGONIST [J].
ADVENIER, C ;
GIRARD, V ;
NALINE, E ;
VILAIN, P ;
EMONDSALT, X .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (01) :169-171
[2]   NEUROKININ A (NK2) RECEPTOR REVISITED WITH SR-48968, A POTENT NONPEPTIDE ANTAGONIST [J].
ADVENIER, C ;
ROUISSI, N ;
NGUYEN, QT ;
EMONDSALT, X ;
BRELIERE, JC ;
NELIAT, G ;
NALINE, E ;
REGOLI, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (03) :1418-1424
[3]  
ADVENIER C, 1996, AM J RESP CRIT CARE, V153, pA163
[4]  
Ball D. I., 1994, British Journal of Pharmacology, V112, p48P
[5]   MODULATION OF NEUROTRANSMISSION IN AIRWAYS [J].
BARNES, PJ .
PHYSIOLOGICAL REVIEWS, 1992, 72 (03) :699-729
[6]   The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist [J].
Beattie, DT ;
Beresford, IJM ;
Connor, HE ;
Marshall, FH ;
Hawcock, AB ;
Hagan, RM ;
Bowers, J ;
Birch, PJ ;
Ward, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (08) :3149-3157
[7]   INVOLVEMENT OF NEUROGENIC INFLAMMATION IN ANTIGEN-INDUCED BRONCHOCONSTRICTION IN GUINEA-PIGS [J].
BERTRAND, C ;
GEPPETTI, P ;
GRAF, PD ;
FORESI, A ;
NADEL, JA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (05) :L507-L511
[8]   CAPSAICIN INCREASES AIR-FLOW RESISTANCE IN GUINEA-PIGS IN-VIVO BY ACTIVATING BOTH NK(2) AND NK(1) TACHYKININ RECEPTORS [J].
BERTRAND, C ;
NADEL, JA ;
GRAF, PD ;
GEPPETTI, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04) :909-914
[9]   Mechanisms of action of central and peripheral antitussive drugs [J].
Bolser, DC .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1996, 9 (5-6) :357-364
[10]  
BUCKNER CK, 1993, J PHARMACOL EXP THER, V267, P1168